Atossa Therapeutics
ATOS
$1.46
Share price
-2.01%
Change (1 day)
105.63%
Change (1 year)
Categories
Atossa Therapeutics (ATOS) Fails to deliver data
Key failure to deliver metrics for Atossa Therapeutics:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.54 M
- Last 3 months FTD volume: $0.97 M
- Last year FTD volume: $1.29 M
Failures to deliver for Atossa Therapeutics (ATOS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Atossa Therapeutics (ATOS) - since 2018
Volume in USD (price x number of shares), data since 2018Atossa Therapeutics (ATOS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.97 M | 90.89% |
| 2023 | $0.5 M | -93.57% |
| 2022 | $7.92 M | -92.88% |
| 2021 | $0.11 B | 731.9% |
| 2020 | $13.37 M | -10.09% |
| 2019 | $14.87 M | 138.47% |
| 2018 | $6.23 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.59 B | 🇺🇸 USA |
 Quest Diagnostics
DGX | $4.68 M | $45.4 M | 🇺🇸 USA |
 LabCorp LH | $11.82 M | $53.7 M | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | $0.05 M | $13.8 M | 🇺🇸 USA |
 NeoGenomics
NEO | $3.21 M | $5.87 M | 🇺🇸 USA |
 Enzo Biochem ENZ | $0 M | $0.63 M | 🇺🇸 USA |